---
title: CDMO Daily News — October 6, 2026
slug: daily-news-2026-10-06-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: October 6 CDMO daily: Lonza and Asimov Partner on Lentiviral Vector GMP Manufacturing; Curia Invests $28M in Sterile API Expansion at Valladolid Site —…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-10-06-cdmo
published_at: 2026-10-06T00:00:49.757Z
last_updated: 2026-10-06T00:01:28.434Z
---

### [Lonza](/companies/lonza) and [Asimov](/companies/asimov) Partner on Lentiviral Vector GMP Manufacturing
- [Lonza](/companies/lonza) and [Asimov](/companies/asimov) combine Asimov's LV Edge stable cell line technology with Lonza's process development, scale-up, analytics, and GMP manufacturing capabilities for lentiviral vectors.
- The collaboration addresses scalability and consistency limitations of current multi-plasmid transient transfection methods, targeting in vivo and ex vivo gene therapy applications.
- Partnership spans transgene optimization, cell line development, process development, advanced analytics, scale-up, GMP manufacturing, and CMC readiness.

**Operational Impact**

[Lonza](/companies/lonza)'s expanded lentiviral vector GMP capabilities and feasibility-first framework with [Asimov](/companies/asimov) create a defined pathway for gene therapy developers to transition from early design through clinical and commercial manufacturing, potentially increasing demand for Lonza's specialized modalities capacity.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/lonza-and-asimov-partner-to-advance-lentiviral-vector-manufacturing)*

---

### [Curia](/companies/curiaglobal) Invests $28M in Sterile API Expansion at Valladolid Site
- [Curia](/companies/curiaglobal) is investing $28 million to expand sterile API manufacturing for steroid and non-steroid products at its Valladolid, Spain facility, with completion targeted for Q4 2028.
- The expansion adds closed-system barrier isolators for aseptic handling and enables variable batch-size manufacturing from grams to metric tons for injectable suspensions and complex sterile formulations.
- This follows Curia's $4 million API aseptic suite upgrade in Valladolid (May 2026) and concurrent expansions in New Mexico and Glasgow, signaling multi-geography capacity growth.

**Operational Impact**

[Curia](/companies/curiaglobal)'s Valladolid sterile API expansion adds European capacity for variable-batch injectable manufacturing, reducing lead times and supply risk for sponsors developing complex sterile formulations.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/curia-invests-28m-to-expand-sterile-api-manufacturing-capability)*

---

### [MedPharm](/companies/medpharm) Lands Fifth Commercial Manufacturing Deal in 20 Months
- [MedPharm](/companies/medpharm) signed a commercial manufacturing agreement with a global pharma company for a branded specialty topical product, marking its fifth deal in 20 months.
- The Durham, North Carolina site will handle site transfer and commercial production, generating technology transfer revenue in 2026–2027 and manufacturing revenue starting 2027.

**Operational Impact**

[MedPharm](/companies/medpharm)'s Durham site adds another commercial topical manufacturing program, demonstrating sustained demand for its specialty formulation capabilities and expanding its commercial revenue base into 2027.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/medpharm-secures-fifth-commercial-manufacturing-deal-in-20-months)*

## References

1. [PharmaSource RSS — Lonza and Asimov Partner on Lentiviral Vector GMP Manufacturing](https://pharmasource.global/content/news/cdmo-news/lonza-and-asimov-partner-to-advance-lentiviral-vector-manufacturing)
2. [Contract Pharma Breaking News RSS — Curia Invests $28M in Sterile API Expansion at Valladolid Site](https://www.contractpharma.com/breaking-news/curia-invests-28m-to-expand-sterile-api-manufacturing-capability)
3. [Contract Pharma Breaking News RSS — MedPharm Lands Fifth Commercial Manufacturing Deal in 20 Months](https://www.contractpharma.com/breaking-news/medpharm-secures-fifth-commercial-manufacturing-deal-in-20-months)

Source: https://www.cdmo.directory/posts/daily-news-2026-10-06-cdmo